Saha Saurabh
Chief Executive Officer | Director
2 companies
Insider Signal Score
39
WeakTrades Analyzed
29
12M Win Rate
8.0%
Avg 3M Return
-11.2%
Avg 12M Return
-46.1%
Saha Saurabh is a Chief Executive Officer at Centessa Pharmaceuticals plc with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 15 sells.
Estimated insider holdings value: $11.3M based on current market prices.
Holdings by Company
Transaction History
Showing 10 filings (page 2)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | CNTA Centessa Pharmaceuticals Plc | Chief Executive Officer | Sale+OE | 299 | $18.23 | $5,450.77 | - | -8.4% | +69.4% | |
| Nov 22, 2024 | CNTA Centessa Pharmaceuticals Plc | Chief Executive Officer | Sale+OE | 60,182 | $17.00 | $1,023,225.72 | -3.4% | -1.7% | +64.2% | |
| Nov 13, 2024 | CNTA Centessa Pharmaceuticals Plc | Chief Executive Officer | Sale+OE | 32,023 | $18.28 | $585,418.87 | -4.8% | -4.5% | +43.6% | |
| Oct 23, 2024 | CNTA Centessa Pharmaceuticals Plc | Chief Executive Officer | Sell | 55,000 | $15.70 | $863,727.20 | -2.8% | +8.6% | +59.3% | |
| Sep 20, 2024 | CNTA Centessa Pharmaceuticals Plc | Chief Executive Officer | Sell | 55,000 | $16.53 | $908,985.00 | -7.1% | +5.9% | +37.5% | |
| Sep 10, 2024 | CNTA Centessa Pharmaceuticals Plc | Chief Executive Officer | Sale+OE | 175,000 | $16.52 | $2,891,822.50 | -18.4% | +23.9% | +55.8% | |
| Aug 30, 2024 | CLVT Clarivate Plc | Director | Sell | 17,646 | $6.75 | $119,110.50 | -42.6% | -16.5% | -36.6% | |
| Aug 23, 2024 | CNTA Centessa Pharmaceuticals Plc | Chief Executive Officer | Sell | 46,651 | $12.30 | $573,905.27 | -5.7% | +41.6% | +32.4% | |
| Aug 22, 2024 | CNTA Centessa Pharmaceuticals Plc | Chief Executive Officer | Sell | 8,349 | $12.28 | $102,545.95 | -0.3% | +37.2% | +39.4% | |
| Jun 24, 2022 | CNTA Centessa Pharmaceuticals Plc | Chief Executive Officer | Buy | 10,000 | $4.63 | $46,284.00 | +35.7% | -5.7% | +43.5% |